In pancreatic cancer for example, loss of SMAD4 impairs T-cell infiltration and chemokine production, leading to a poorly immunogenic tumor microenvironment with reduced IFNγ-driven PD-L1 expression [59]. This evidence concerns the gene SMAD4 and familial pancreatic carcinoma.